Essential role of high concentrations of interleukin-2 to maintain growth and functions of human interleukin-2-activated natural killer cells

被引:0
|
作者
Nagashima, S [1 ]
Morikawa, H [1 ]
Yoda, N [1 ]
Niwa, A [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Microbiol, Mibu, Tochigi 3210293, Japan
来源
INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 2000年 / 16卷 / 1-2期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the effects of interleukin-2 (IL-2) on growth and cytotoxicity functions of human natural killer (NK) cells in culture. it is weil known that a high dose of IL-2 is necessary to develop IL-2-activated NK (A-NK) cells from human lymphocytes at an early stage in culture. After culture in the presence of 6,000 IU/ml of IL-2 for 10 days, A-NK cells were further incubated with or without 6,000 IU/ml of IL-2 for 48-96 h. Growth of A-NK cells was dependent on the presence of IL-2. Elimination of IL-2 resulted in the down-regulation of IL-2 receptor alpha -chain expression and the up-regulation of that of the beta -chain on A-NK cells. A-NK cells incubated with IL-2 had increased expression of Fas ligand and CD56, CD54 and CD11a molecules compared with the cells incubated without IL-2. A-NK cells incubated without IL-2 secreted both tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma in significantly lower amounts than those secreted by the cells incubated with IL-2. After incubation with IL-2, A-NK cells showed that the cytolytic activity against NK-sensitive K-562 targets was significantly higher than that of A-NK cells after incubation without IL-2. While A-NK cells after incubation with IL-2 also lysed NK-resistant HR targets, the cells incubated without IL-2 did not. in addition, A-NK cells after incubation with IL-2 induced DNA fragmentation in HR targets significantly more than in A-NK cells after incubation without IL-2. This study demonstrates that a high dose of IL-2 is necessary to maintain growth and some antitumor activities of A-NK cells.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [41] Expression of BCL-2 in human natural killer cells and its induction by interleukin-2
    Jiang, S
    Munker, R
    Andreeff, M
    BLOOD, 1995, 86 (10) : 2854 - 2854
  • [42] HUMAN NATURAL-KILLER (NK) CELLS PRODUCE INTERLEUKIN-2 (IL-2)
    DOMZIG, W
    TIMONEN, TT
    STADLER, BM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 309 - 309
  • [43] REGULATION OF HEPATIC REGENERATION BY INTERLEUKIN-2-ACTIVATED KILLER CELLS AND EFFECT OF CYCLOSPORINE-A
    HIZUTA, A
    TANAKA, N
    URABE, T
    YAMAMOTO, H
    OKAMOTO, Y
    TATEMOTO, A
    OHNO, S
    MURAKAMI, H
    ORITA, K
    BRITISH JOURNAL OF SURGERY, 1988, 75 (12) : 1245 - 1245
  • [44] THYROID FUNCTIONS IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    KUNG, AWC
    LAI, CL
    WONG, KL
    TAM, CF
    QUARTERLY JOURNAL OF MEDICINE, 1992, 82 (297): : 33 - 42
  • [45] Effect of heat-pretreatment on interleukin-2-activated killer cells for in vitro purging
    Tanaka, M
    Honda, J
    Imamura, Y
    Shiraishi, K
    Tanaka, K
    Oizumi, K
    PATHOBIOLOGY, 2000, 68 (03) : 124 - 128
  • [46] Interleukin-18 Synergism with Interleukin-2 in Cytotoxicity and NKG2D Expression of Human Natural Killer Cells
    Qi, Yuan-Ying
    Lu, Chao
    Ju, Ying
    Wang, Zi-E
    Li, Yuan-Tang
    Shen, Ya-Juan
    Lu, Zhi-Ming
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (18) : 7857 - 7861
  • [47] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [48] INTERLEUKIN-2 REGULATION OF HUMAN NATURAL-KILLER-CELLS - ANALYSIS OF MOLECULAR EVENTS
    ORTALDO, JR
    YAMADA, S
    KOVACS, EJ
    PEPPOLONI, S
    YOUNG, H
    FARRAR, W
    RUSCETTI, F
    FEDERATION PROCEEDINGS, 1986, 45 (04) : 998 - 998
  • [49] EFFECT OF INTERLEUKIN-2 ON THE INHIBITION OF HUMAN NATURAL-KILLER ACTIVITY BY MONOLAYER CELLS
    HEISKALA, M
    TIMONEN, T
    CELLULAR IMMUNOLOGY, 1987, 110 (02) : 209 - 217
  • [50] THE TREATMENT OF PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
    ROSENBERG, SA
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY, 1987, 23 (03): : A52 - A52